Literature DB >> 33672678

Identification of Key Candidate Genes Involved in the Progression of Idiopathic Pulmonary Fibrosis.

Yu Cui1,2, Jie Ji1,2, Jiwei Hou1,2, Yi Tan1,2, Xiaodong Han1,2.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a lethal, agnogenic interstitial lung disease with limited therapeutic options. To investigate vital genes involved in the development of IPF, we integrated and compared four expression profiles (GSE110147, GSE53845, GSE24206, and GSE10667), including 87 IPF samples and 40 normal samples. By reanalyzing these datasets, we managed to identify 62 upregulated genes and 20 downregulated genes in IPF samples compared with normal samples. Differentially expressed genes (DEGs) were analyzed by gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to illustrate relevant pathways of IPF, biological processes, molecular function, and cell components. The DEGs were then subjected to protein-protein interaction (PPI) for network analysis, serving to find 11 key candidate genes (ANXA3, STX11, THBS2, MMP1, MMP9, MMP7, MMP10, SPP1, COL1A1, ITGB8, IGF1). The result of RT-qPCR and immunohistochemical staining verified our finding as well. In summary, we identified 11 key candidate genes related to the process of IPF, which may contribute to novel treatments of IPF.

Entities:  

Keywords:  IGF-1; IPF; MMP; OPN; intergrin

Mesh:

Substances:

Year:  2021        PMID: 33672678      PMCID: PMC7924352          DOI: 10.3390/molecules26041123

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  45 in total

1.  TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis.

Authors:  Jiwei Hou; Tan Ma; Honghui Cao; Yabing Chen; Cong Wang; Xiang Chen; Zou Xiang; Xiaodong Han
Journal:  J Cell Physiol       Date:  2017-08-25       Impact factor: 6.384

2.  Discovery of an Orally Bioavailable Pan αv Integrin Inhibitor for Idiopathic Pulmonary Fibrosis.

Authors:  Niall A Anderson; Sebastien Campos; Sharon Butler; Royston C B Copley; Ian Duncan; Stephen Harrison; Joelle Le; Rosemary Maghames; Aleix Pastor-Garcia; John M Pritchard; James E Rowedder; Claire E Smith; Jack Thomas; Giovanni Vitulli; Simon J F Macdonald
Journal:  J Med Chem       Date:  2019-09-23       Impact factor: 7.446

Review 3.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

Review 4.  The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia.

Authors:  K J Hatfield; H Reikvam; Ø Bruserud
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 5.  Approaching the degradome in idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Moisés Selman; Naftali Kaminski
Journal:  Int J Biochem Cell Biol       Date:  2007-12-08       Impact factor: 5.085

6.  MMP expression and abnormal lung permeability are important determinants of outcome in IPF.

Authors:  S McKeown; A G Richter; C O'Kane; D F McAuley; D R Thickett
Journal:  Eur Respir J       Date:  2008-10-01       Impact factor: 16.671

Review 7.  The complex biology of the receptor for the insulin-like growth factor-1.

Authors:  Gaetano Romano
Journal:  Drug News Perspect       Date:  2003-10

8.  Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice.

Authors:  Jeffrey S Berman; David Serlin; Xinfang Li; Geoffrey Whitley; John Hayes; David C Rishikof; Dennis A Ricupero; Lucy Liaw; Margaret Goetschkes; Anthony W O'Regan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-02-20       Impact factor: 5.464

9.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

Review 10.  The insulin-like growth factor system and cancer.

Authors:  Derek LeRoith; Charles T Roberts
Journal:  Cancer Lett       Date:  2003-06-10       Impact factor: 8.679

View more
  2 in total

1.  Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5.

Authors:  Xinh-Xinh Nguyen; Ludivine Renaud; Carol Feghali-Bostwick
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

2.  The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix.

Authors:  Jeremy A Herrera; Lewis Dingle; M Angeles Montero; Rajamiyer V Venkateswaran; John F Blaikley; Craig Lawless; Martin A Schwartz
Journal:  JCI Insight       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.